• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

49.8 kDa菌毛亚基对感染的交叉保护性分析。 (你提供的原文中against前缺少具体病原体名称,翻译可能不太准确,建议补充完整后再翻译)

Cross Protectivity Analysis of 49.8 kDa Pili Subunits of against Infection.

作者信息

Yuni Nur Hidayati Dwi, Rully Septha, Amalia Aisyah, Larissa Widyani Elsa, Indraswari Genitri, Prasetya Adrian, Soraya Merika, Winarsih Sri, Reto Prawiro Sumarno

机构信息

Department of Clinical Microbiology, Faculty of Medicine, University of Brawijaya, Malang, Indonesia.

Master Program in Biomedical Science, Faculty of Medicine, University of Brawijaya, Malang, Indonesia.

出版信息

Interdiscip Perspect Infect Dis. 2022 Jun 15;2022:3751521. doi: 10.1155/2022/3751521. eCollection 2022.

DOI:10.1155/2022/3751521
PMID:35757682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217611/
Abstract

BACKGROUND

Although the AMV and AMS vaccine candidates have similar characteristics as hemagglutinin and adhesive molecules, there are differences in molecular weight.

OBJECTIVE

The research aims to determine the immunological cross-reaction between AMS and AMV.

METHOD

Antihemagglutination test used the anti-adhesion molecular antibody AMS. Next, we examined the immune response that has to be linked with protectivity. The model of the research uses MLIL. The sample separated the mice into four groups, and each group had five mice. The first group was the negative control group. The second group was given AMV and infected with . The third group was immunized with AMV before being exposed to . The last group was infected with . The immune response results were evaluated by calculating the weight of MLIL and counting the colony of bacteria. We also examined other AMS immune responses, namely, -defensin and s-IgA levels. To get the data, we measured the number of Th17 immune effector cells, T-reg, and proinflammatory cytokine IL-17A. Data analysis was performed using ANOVA, independent -test, Kruskal-Wallis, and Mann-Whitney tests.

RESULTS

An antihemagglutination cross immune response, intestinal weight, the number of bacterial colonies, and other findings were found to be significant ( < 0.05) for the levels of -defensin, s-IgA, Th17, T-reg, and IL-17A.

CONCLUSION

The 49.8 kDa·MW protein subunit of the adhesion molecule could act as a candidate vaccine homologous for shigellosis and cholera in the future.

摘要

背景

尽管AMV和AMS候选疫苗具有与血凝素和粘附分子相似的特征,但分子量存在差异。

目的

本研究旨在确定AMS与AMV之间的免疫交叉反应。

方法

抗血凝试验使用抗粘附分子抗体AMS。接下来,我们检测了与保护性相关的免疫反应。研究模型采用MLIL。将小鼠样本分为四组,每组五只小鼠。第一组为阴性对照组。第二组给予AMV并感染……。第三组在接触……之前用AMV免疫。最后一组感染……。通过计算MLIL的重量和计数细菌菌落来评估免疫反应结果。我们还检测了其他AMS免疫反应,即防御素和s-IgA水平。为了获取数据,我们测量了Th17免疫效应细胞、Treg和促炎细胞因子IL-17A的数量。数据分析采用方差分析、独立样本t检验、Kruskal-Wallis检验和Mann-Whitney检验。

结果

对于防御素、s-IgA、Th17、Treg和IL-17A水平,抗血凝交叉免疫反应、肠道重量、细菌菌落数量及其他结果均具有显著性(P<0.05)。

结论

粘附分子的49.8 kDa·MW蛋白亚基未来可能作为志贺氏菌病和霍乱的同源候选疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/f4f1feebab7d/IPID2022-3751521.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/c847330f5e28/IPID2022-3751521.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/6bf287f9018f/IPID2022-3751521.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/5fe204f454a1/IPID2022-3751521.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/27794e5204a8/IPID2022-3751521.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/25410339ed9c/IPID2022-3751521.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/cd432f527d35/IPID2022-3751521.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/a3ff3c921832/IPID2022-3751521.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/f4f1feebab7d/IPID2022-3751521.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/c847330f5e28/IPID2022-3751521.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/6bf287f9018f/IPID2022-3751521.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/5fe204f454a1/IPID2022-3751521.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/27794e5204a8/IPID2022-3751521.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/25410339ed9c/IPID2022-3751521.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/cd432f527d35/IPID2022-3751521.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/a3ff3c921832/IPID2022-3751521.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/9217611/f4f1feebab7d/IPID2022-3751521.008.jpg

相似文献

1
Cross Protectivity Analysis of 49.8 kDa Pili Subunits of against Infection.49.8 kDa菌毛亚基对感染的交叉保护性分析。 (你提供的原文中against前缺少具体病原体名称,翻译可能不太准确,建议补充完整后再翻译)
Interdiscip Perspect Infect Dis. 2022 Jun 15;2022:3751521. doi: 10.1155/2022/3751521. eCollection 2022.
2
Generating mucosal and systemic immune response following vaccination of adhesion molecule against infection.接种黏附分子疫苗后产生黏膜和全身免疫应答
Indian J Med Microbiol. 2020 Jan-Mar;38(1):37-45. doi: 10.4103/ijmm.IJMM_19_411.
3
vaccine development: Oral administration of peptides derived from the 49.8 kDa pili protein subunit activates the intestinal immune response in mice.疫苗研发:口服源自49.8 kDa菌毛蛋白亚基的肽可激活小鼠的肠道免疫反应。
Vet World. 2022 Feb;15(2):281-287. doi: 10.14202/vetworld.2022.281-287. Epub 2022 Feb 11.
4
Peptide Sequence of Pili Subunit Protein 49.8 kDa as Antigenic Epitope for Shigellosis Vaccine Development.菌毛亚基蛋白49.8 kDa的肽序列作为志贺氏菌病疫苗开发的抗原表位
Turk J Pharm Sci. 2022 Dec 21;19(6):649-656. doi: 10.4274/tjps.galenos.2021.75031.
5
Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.福氏志贺菌2a和宋内志贺菌双价侵袭素复合物(Invaplex)疫苗的研发与评估
Vaccine. 2006 Mar 20;24(13):2290-301. doi: 10.1016/j.vaccine.2005.11.040. Epub 2005 Dec 5.
6
IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.负载IpaD的N-三甲基壳聚糖纳米颗粒可有效保护豚鼠免受福氏志贺菌感染。
Iran J Immunol. 2019 Sep;16(3):212-224. doi: 10.22034/IJI.2019.80272.
7
An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.一种嵌合亚基免疫原方法可有效抵御志贺氏菌的毒性、III型和V型分泌系统。
Int Immunopharmacol. 2021 Nov;100:108132. doi: 10.1016/j.intimp.2021.108132. Epub 2021 Sep 8.
8
Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity.Th17 细胞是志贺氏菌激活诱导的优势 T 细胞亚群,介导保护性免疫。
J Immunol. 2010 Feb 15;184(4):2076-85. doi: 10.4049/jimmunol.0900978. Epub 2010 Jan 20.
9
Development of recombinant vaccine candidate molecule against Shigella infection.抗志贺氏菌感染重组疫苗候选分子的研发。
Vaccine. 2016 Oct 17;34(44):5376-5383. doi: 10.1016/j.vaccine.2016.08.034. Epub 2016 Aug 31.
10
Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.在乳球菌中异源表达 Intimin 和 IpaB 融合蛋白及其黏膜传递可在小鼠模型中引发对大肠杆菌 O157 和福氏志贺菌致病性的保护。
Int Immunopharmacol. 2020 Aug;85:106617. doi: 10.1016/j.intimp.2020.106617. Epub 2020 May 25.

引用本文的文献

1
Vaccines: The Continuing Unmet Challenge.疫苗:持续未被满足的挑战。
Int J Mol Sci. 2024 Apr 13;25(8):4329. doi: 10.3390/ijms25084329.

本文引用的文献

1
Shigellosis.志贺菌病。
Lancet. 2018 Feb 24;391(10122):801-812. doi: 10.1016/S0140-6736(17)33296-8. Epub 2017 Dec 16.
2
Interleukin-17A (IL-17A) and IL-17F Are Critical for Antimicrobial Peptide Production and Clearance of Staphylococcus aureus Nasal Colonization.白细胞介素-17A(IL-17A)和白细胞介素-17F对于抗菌肽的产生及清除金黄色葡萄球菌鼻腔定植至关重要。
Infect Immun. 2016 Nov 18;84(12):3575-3583. doi: 10.1128/IAI.00596-16. Print 2016 Dec.
3
Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.
运用定量分子诊断方法确定儿童腹泻病因:全球儿童急性腹泻病监测研究病例对照研究的重新分析
Lancet. 2016 Sep 24;388(10051):1291-301. doi: 10.1016/S0140-6736(16)31529-X.
4
Updated global burden of cholera in endemic countries.流行国家霍乱的全球负担最新情况。
PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003832. doi: 10.1371/journal.pntd.0003832. eCollection 2015.
5
Antimicrobial Human β-Defensins in the Colon and Their Role in Infectious and Non-Infectious Diseases.肠道中的抗菌人 β-防御素及其在感染性和非传染性疾病中的作用。
Pathogens. 2013 Mar 19;2(1):177-92. doi: 10.3390/pathogens2010177.
6
Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses.生发中心在多个派伊尔氏结中的再利用导致高度同步、寡克隆和亲和力成熟的肠道 IgA 应答。
Mucosal Immunol. 2013 Jan;6(1):122-35. doi: 10.1038/mi.2012.56. Epub 2012 Jul 11.
7
Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs.耳部皮内免疫霍乱毒素及其无毒β亚单位促进依赖于迁移 DC 的有效 Th1 和 Th17 分化。
Eur J Immunol. 2011 Oct;41(10):2894-904. doi: 10.1002/eji.201040997.
8
Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.分泌型IgA介导的福氏志贺菌中和作用通过下调炎症信号通路预防肠道组织破坏。
J Immunol. 2009 Nov 1;183(9):5879-85. doi: 10.4049/jimmunol.0901838. Epub 2009 Oct 14.
9
Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens.经鼻递送霍乱毒素可诱导以Th17为主导的针对旁观者抗原的T细胞应答。
PLoS One. 2009;4(4):e5190. doi: 10.1371/journal.pone.0005190. Epub 2009 Apr 10.
10
Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine.特定的微生物群引导小肠黏膜中产生白细胞介素-17的辅助性T细胞的分化。
Cell Host Microbe. 2008 Oct 16;4(4):337-49. doi: 10.1016/j.chom.2008.09.009.